Skip to main content
Thursday, September 24, 2026
BTC $84,201 ▼ 0.22%
GOKHSHTEIN
.
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Sections
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More Sections
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
Menu
×
News
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
LIVE
ADA
$0.244
up
+2.31%
ETH
$2,667
down
−0.64%
LINK
$12.53
up
+1.40%
SOL
$114.95
down
−0.05%
BTC
$84,201
down
−0.22%
XRP
$1.50
down
−0.08%
S&P 500
7,691
down
−0.20%
Nasdaq
26,787
down
−0.55%
Dow
51,362
down
−0.29%
RUT
2,824
down
−0.52%
TNX
5.09%
down
−0.41%
TYX
5.39%
down
−0.19%
FVX
4.97%
down
−0.48%
IRX
4.03%
up
+0.10%
VIX
15.69
up
+3.36%
GOLD
$4,304.90
down
−0.31%
SILVER
$63.85
down
−1.71%
OIL
$94.06
up
+2.06%
DXY
101.22
up
+0.12%
NVDA
$222.24
down
−1.45%
AAPL
$337.58
up
+0.17%
TSLA
$379.55
down
−0.15%
META
$762.83
up
+2.52%
MSFT
$492.79
down
−1.56%
AMZN
$246.31
down
−1.19%
GOOGL
$338.63
up
+0.24%
Fear & Greed
71 — Greed
ADA
$0.244
up
+2.31%
ETH
$2,667
down
−0.64%
LINK
$12.53
up
+1.40%
SOL
$114.95
down
−0.05%
BTC
$84,201
down
−0.22%
XRP
$1.50
down
−0.08%
S&P 500
7,691
down
−0.20%
Nasdaq
26,787
down
−0.55%
Dow
51,362
down
−0.29%
RUT
2,824
down
−0.52%
TNX
5.09%
down
−0.41%
TYX
5.39%
down
−0.19%
FVX
4.97%
down
−0.48%
IRX
4.03%
up
+0.10%
VIX
15.69
up
+3.36%
GOLD
$4,304.90
down
−0.31%
SILVER
$63.85
down
−1.71%
OIL
$94.06
up
+2.06%
DXY
101.22
up
+0.12%
NVDA
$222.24
down
−1.45%
AAPL
$337.58
up
+0.17%
TSLA
$379.55
down
−0.15%
META
$762.83
up
+2.52%
MSFT
$492.79
down
−1.56%
AMZN
$246.31
down
−1.19%
GOOGL
$338.63
up
+0.24%
Fear & Greed
71 — Greed
Tag
telehealth
3 articles
Research & Analysis
44d ago
Hims & Hers Beats Revenue Estimates but Cuts Profit Forecast on Growth Spending
Q2 revenue of $753.2 million topped estimates by 7.8 percent, but a trimmed full-year adjusted EBITDA forecast sent shares down 9.7 percent.
U.S. Equities
129d ago
Teladoc Faces Competitive Pressure as Growth Slows, Reimbursement Tightens
Teladoc's stretched valuation and profitability challenges make it a risky bet as telehealth adoption normalizes
U.S. Equities
161d ago
Hims & Hers Jumps on Peptide Reassessment: Multi-Billion Dollar Opportunity Unlocked
Hims & Hers Health, Inc. stock rallied sharply today after the U.S. government confirmed it would reassess the regulatory framework for popular peptides, signaling a substantial expansion opportunity for the telehealth provider.